TCL Archive FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe December 5, 1986
TCL Archive NCI’s Otis Brawley Named Professor At Emory, Associate Director, Cancer Control, At Winship. April 20, 2001
TCL Archive In Brief: Conferees Ok NCI Appropriations At $691.7 Million; Final Amount Available Won’t Be Set Until Spring November 29, 1974
TCL Archive Yervoy-Nivolumab Combination Treatment Shrinks Tumors 80 Percent in Three Months May 31, 2013
